intresting timing- why now before Brazil approval?
The fact that PLX can't by itself develope its "platform" is known to all of us... This is why insiders sold so many shares including when FDA approved their drug. The question is why the board has decided to sell the company to PFE or anby third party before Brazil is finished.... or has Brazil ( which according to CEO was supposed to be approved by 2012 end of the year ) intentionally delayed? Timing is very strange... it is clear thaty no company will get into a deal with PLX other than PFE... This is why the price is a problem because PFE knows that PLX has no real alternative. Getting cooperation with other companies on other drugs never worked and it looks like there are several reasons for that one of which is the PFE agreement and existing business relations. Therefore the shareholders are stuck and want a way out in a relatively modest price. For PFE it is a great opportunity I just hope they understand that if they wait to long to sign a deal few shareholders may want to block it due to the strange timing...and a final question to CEO- if the Company has a real and valid platform as you kept claiming what selling so cheap?
Pfizer obviously could be considered a potential buyer. But there are MANY other companies
trying to get into the protein synthesis game. All options need to be considered.
Not sure why you are negative about the platform. The FDA approved a drug that used it so there is certainly some real science behind it. Many proteins need to be synthesized more cheaply. I'm sure the plant-based platform could be used effectively.